Dr. Apostolos Zaravinos is a Professor of Cancer Genetics in the Department of Life Sciences at the European University Cyprus. He received his B.Sc. in Molecular Biology from the Department of Biology of the University of Crete in 2004, and his Ph.D. in Medicine from the Medical School of the same University in 2008. He worked as a Research Scientist at the Harris Birthright Research Center for Fetal Medicine at King’s College Hospital (2009-2010) and performed postdoctoral research in Cancer Genetics at the Molecular Medicine Research Center of the University of Cyprus (2011-2013). He completed his postdoctoral training in Immunogenetics and Cancer Genetics at the Department of Laboratory Medicine of the Karolinska Institute (2013-2015). He was appointed Assistant Professor of Cancer Genetics at the European University Cyprus in 2015 and promoted to the rank of Associate Professor in 2019. He has also worked as an Associate Professor of Genetics at the Department of Basic Medical Science, College of Medicine (CMED) at Qatar University (2020-2021). Dr. Zaravinos holds two specializations: one in “Systems Biology” from the Systems Biology Center at the Icahn School of Medicine, at Mount Sinai (2015) and another in “Genomic Data Science” from the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University (2018). He has worked as a Guest Editor for several Special Issues in scientific journals and as an Associate Faculty Member of the F1000Prime (2013-2015). He is the recipient of the Science Award (2017) from the Youth Board of Cyprus and the first Young Investigator Award from the Bank of Cyprus Oncology Centre (2017). He is also a member of the EACR, AACR, FEBS, Swedish Society for Biochemistry and the ECCO, among others. He has authored >125 original research articles and 7 book chapters (h-index, 35; >3,600 citations; Scopus). Dr. Zaravinos' research aims towards an advanced understanding of carcinogenesis through the investigation of interactions between genes. His interests also focus on Cancer Immunogenetics, aiming to elucidate how the tumor microenvironment relates to different aspects of the tumor’s biology. In particular, he is interested in the examination of the immune landscape of inflamed tumors, including colorectal cancer and skin melanoma, using next-generation sequencing approaches.